{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:59:43Z","timestamp":1789977583901,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1989,1]]},"DOI":"10.1007\/bf01665025","type":"journal-article","created":{"date-parts":[[2005,5,9]],"date-time":"2005-05-09T00:52:27Z","timestamp":1115599947000},"page":"13-20","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens"],"prefix":"10.1007","volume":"30","author":[{"given":"Suzanne A.","family":"Eccles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen P.","family":"Purvies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Styles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"3378","volume":"45","author":"GL Buraggi","year":"1985","unstructured":"Buraggi GL, Callegaro L, Mariani G, Turvin A, Cascinelli N, Attili A, Bombardier E, Terno G, Plassic G, Dovis M, Mazzuca N, Natali P, Scasselati GA, Rosa U, Ferrone S (1985) Imaging with131I-labelled monoclonal antibodies to a high molecular weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab\u2032)2 fragments. Cancer Res 45: 3378","journal-title":"Cancer Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4049\/jimmunol.115.3.844","volume":"115","author":"C Cheers","year":"1975","unstructured":"Cheers C, Waller R (1975) Activated macrophages in congenitally athymic nude mice and in lethally-irradiated mice. J Immunol 115: 844","journal-title":"J Immunol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0090-1229(80)90084-7","volume":"17","author":"WH Jong De","year":"1980","unstructured":"De Jong WH, Steerenberg PA, Ursem PS, Osterhaus A, Vos JG, Ruitenberg EJ (1980) The athymic nude rat. III. Natural cell-mediated cytotoxicity. Clin Immunol Immunopathol 17: 163","journal-title":"Clin Immunol Immunopathol"},{"key":"CR4","first-page":"69","volume":"62","author":"S Denham","year":"1987","unstructured":"Denham S, Barfoot R, Jackson E (1987) A receptor for monomeric IgG2b on rat macrophages. Immunology 62: 69","journal-title":"Immunology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/bjc.1979.264","volume":"40","author":"SA Eccles","year":"1979","unstructured":"Eccles SA, Styles JM, Hobbs SM, Dean CJ (1979) Metastasis in the nude rat associated with lack of immune response. Br J Cancer 40: 802","journal-title":"Br J Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.1980.224","volume":"42","author":"SA Eccles","year":"1980","unstructured":"Eccles SA, Heckford SE, Alexander P (1980) Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours. Br J Cancer 42: 252","journal-title":"Br J Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1084\/jem.157.2.807","volume":"157","author":"AB Ezekowitz","year":"1983","unstructured":"Ezekowitz AB, Bampton M, Gordon S (1983) Macrophage activation selectively enhances expression of Fc receptors for IgG2a. J Exp Med 157: 807","journal-title":"J Exp Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ijc.2910160204","volume":"16","author":"RB Herberman","year":"1975","unstructured":"Herberman RB, Nunn ME, Laurin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumours. 1. Distribution of reactivity and specificity. Int J Cancer 16: 216","journal-title":"Int J Cancer"},{"key":"CR9","first-page":"123","volume":"24","author":"SM Larson","year":"1983","unstructured":"Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom H, Hellstrom KE (1983). Imaging of melanoma with I-131-labelled monoclonal antibodies. J Nucl Med 24: 123","journal-title":"J Nucl Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19841001)54:7<1318::AID-CNCR2820540715>3.0.CO;2-J","volume":"54","author":"BD Mann","year":"1984","unstructured":"Mann BD, Cohen M, Saxton R, Morton D, Benedict WF, Korn E, Spolter L, Graham L, Chang C, Burk M (1984) Imaging of human tumour xenografts in nude mice with radiolabelled monoclonal antibodies: limitations of specificity due to non-specific uptake of antibody. Cancer 54: 1318","journal-title":"Cancer"},{"key":"CR11","volume-title":"Cancer immunology: innovative approaches to therapy","author":"AC Morgan","year":"1986","unstructured":"Morgan AC, Foon KA (1986) Monoclonal antibody therapy of cancer: preclinical models and investigations in humans In: Herberman (ed) Cancer immunology: innovative approaches to therapy. Martinus Nijhoff, Netherlands"},{"key":"CR12","first-page":"2376","volume":"45","author":"JL Murray","year":"1985","unstructured":"Murray JL, Rosenblum M, Sobol RE, Bartholomew R, Plager C,Haynie P, Jahns M, Glenn HJ, Lamki L, Benjamin R, Papadopoulos N, Boddie AW, Frinke JM, David G, Carlo D, Hersh E (1985) Radioimaging in malignant melanoma with111I-labelled monoclonal antibody 96.5. Cancer Res 45: 2376","journal-title":"Cancer Res"},{"key":"CR13","first-page":"2382","volume":"45","author":"MG Rosenblum","year":"1985","unstructured":"Rosenblum MG, Murray JL, Haynie TP, Glenn HT, Jahns MF, Benjamin RS, Frinke JM, Carlo D, Hersh EM (1985) Pharmacokinetics of111In-labelled anti p-97 monoclonal antibody in patients with metastatic malignant melanoma. Cancer Res 45: 2382","journal-title":"Cancer Res"},{"key":"CR14","first-page":"303","volume":"35","author":"H Sands","year":"1985","unstructured":"Sands H, Shan SA, Jones PL, Neacy W, Gallagher BM (1985) Non-immunological factors affecting the localisation of monoclonal antibodies in xenografts of human breast and colon tumours. Dev Oncol 35: 303","journal-title":"Dev Oncol"},{"key":"CR15","first-page":"3225","volume":"46","author":"J Schlom","year":"1986","unstructured":"Schlom J (1986) Basic principles and applications of monoclonal antibodies in the management of carcinomas. Cancer Res 46: 3225","journal-title":"Cancer Res"},{"key":"CR16","first-page":"335","volume":"27","author":"SA Shah","year":"1986","unstructured":"Shah SA, Pollock R, Brown B, Gallaher BM, Scharff M, Sands H (1986) Pharmacokinetics and imaging using mutant monoclonal antibodies. Proc Am Assoc Cancer Res 27: 335","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/eji.1830140119","volume":"14","author":"AK Sharp","year":"1984","unstructured":"Sharp AK, Colston MT (1984) The regulation of macrophage activity in congenitally athymic mice. Eur J Immunol 14: 102","journal-title":"Eur J Immunol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00205633","volume":"24","author":"R Wahl","year":"1987","unstructured":"Wahl R, Wilson B, Leibert M, Beirwaltes W (1987) High dose, unlabelled non-specific antibody pretreatment: influence on specific antibody localisation to human melanoma xenografts. Cancer Immunol Immunother 24: 221","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01665025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01665025\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01665025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:40:05Z","timestamp":1683092405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01665025"}},"subtitle":["II. Effect of host age and immune status"],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["BF01665025"],"URL":"https:\/\/doi.org\/10.1007\/bf01665025","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}